Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Purpose</h3><p>Locoregional recurrence (LRR) is the predominant pattern of relapse after non‐surgical treatment of Head and Neck Squamous Cell Cancers (HNSCC). Therefore, accurately identifying patients with HNSCC who are at high risk for LRR is important for optimizing personalized treatment plans. In this work, we developed a multi‐classifier, multi‐objective and multi‐modality (mCOM) radiomics‐based outcome prediction model for HNSCC LRR.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>In mCOM, we considered sensitivity and specificity simultaneously as the objectives to guide the model optimization. We used multiple classifiers, comprising support vector machine (SVM), discriminant analysis (DA), and logistic regression (LR), to build the model. We used features from multiple modalities as model inputs, comprising clinical parameters and radiomics feature extracted from X‐ray computed tomography (CT) images and positron emission tomography (PET) images. We proposed a multi‐task multi‐objective immune algorithm (mTO) to train the mCOM model and used an evidential reasoning (ER)‐based method to fuse the output probabilities from different classifiers and modalities in mCOM. We evaluated the effectiveness of the developed method by using a retrospective public pre‐treatment HNSCC dataset downloaded from The Cancer Imaging Archive (TCIA). The input for our model included radiomic features extracted from pre‐treatment PET and CT using an open source radiomics software and clinical characteristics such as sex, age, stage, primary disease site, human papillomavirus (HPV) status and treatment paradigm. In our experiment, 190 patients from two institutions were used for model training while the remaining 87 patients from the other two institutions were used for testing.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>When we built the predictive model using features from single modality, the multi‐classifier models achieved better performance over the models built with the three base‐classifiers individually. When we built the model using features from multiple modalities, the proposed method achieved area under the receiver operating characteristic curve (AUC) values of 0.76 for the radiomics‐only model, and 0.77 for the model built with radiomics and clinical features, which is significantly higher than the AUCs of models built with single‐modality features. The statistical analysis was performed using MATLAB software.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Comparisons with other methods demonstrated the efficiency of the mTO algorithm and the superior performance of the proposed mCOM model for predicting HNSCC LRR.</p></section>

Subconjunctival haemorrhage: a feature of acute severe asthma.

Rectal Cancer: Assessment of Neoadjuvant Chemoradiation Outcome based on Radiomics of Multiparametric MRI.

Radiomics Model Based on Intratumoral and Peritumoral Features for Predicting Major Pathological Response in Non-Small Cell Lung Cancer Receiving Neoadjuvant Immunochemotherapy

Development and Validation of Prognostic Models Using Radiomic Features from Pre-Treatment Positron Emission Tomography (PET) Images in Head and Neck Squamous Cell Carcinoma (HNSCC) Patients

CT-based Radiomic Signatures for Predicting Histopathologic Features in Head and Neck Squamous Cell Carcinoma.

Development and Validation of Radiomic Signatures of Head and Neck Squamous Cell Carcinoma Molecular Features and Subtypes.

Radiomics strategies for risk assessment of tumour failure in head-and-neck cancer

Head and neck cancer treatment outcome prediction: a comparison between machine learning with conventional radiomics features and deep learning radiomics

Difficult portal vein access in transjugular intrahepatic portosystemic shunt placement.

Prognosis Prediction in Head and Neck Squamous Cell Carcinoma by Radiomics and Clinical Information

Prediction of recurrence free survival of head and neck cancer using PET/CT radiomics and clinical information

Targeting Treatment Resistance in Head and Neck Squamous Cell Carcinoma – Proof of Concept for CT Radiomics-Based Identification of Resistant Sub-Volumes

A multi‐objective radiomics model for the prediction of locoregional recurrence in head and neck squamous cell cancer

Hyperbaric Oxygen in Addition to Antibiotic Therapy Is Effective for Bisphosphonate-Induced Osteonecrosis of the Jaw in a Patient with Multiple Myeloma

18F‑FDG PET/CT Based Radiomics Features Improve Prediction of Prognosis: Multiple Machine Learning Algorithms and Multimodality Applications for Multiple Myeloma

Multiparametric functional MRI and 18F-FDG-PET for survival prediction in patients with head and neck squamous cell carcinoma treated with (chemo)radiation

Non-invasive decision support for clinical treatment of NSCLC using a multiscale radiomics approach

Interpretable survival network for progression risk analysis of multimodality imaging biomarkers in poor-prognosis head and neck cancers

Multi-institutional Prognostic Modeling in Head and Neck Cancer: Evaluating Impact and Generalizability of Deep Learning and Radiomics

Multi-Level Multi-Modality Fusion Radiomics: Application to PET and CT Imaging for Prognostication of Head and Neck Cancer

Enhancing Predictive Accuracy for Recurrence-Free Survival in Head and Neck Tumor: A Comparative Study of Weighted Fusion Radiomic Analysis